Viatris Inc

VTRS · Nasdaq · SIC 2834: Pharmaceutical Preparations
101
SEC Filings

Business Summary

PARTI About Viatris Viatris is a global healthcare company whose breadth and scale we believe make it uniquely positioned to address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, Viatris supplies high-quality medicines to approximately 1 billion patients around the world each year. The Company has a global footprint, an extensive portfolio of medicines that is well-diversified across therapeutic areas, a one-of-a-kind global suppl...

Next Earnings

Q2 FY2026 — expected 2026-08-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVTRSdiscussed_in_filing Cybersecurity
topic_mentionVTRSdiscussed_in_filing Sovereign & Government
topic_mentionVTRSdiscussed_in_filing Cybersecurity
topic_mentionVTRSdiscussed_in_filing Sovereign & Government
topic_mentionVTRSdiscussed_in_filing Healthcare & Bio
topic_mentionVTRSdiscussed_in_filing Sovereign & Government
topic_mentionVTRSdiscussed_in_filing Healthcare & Bio
topic_mentionVTRSdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001792044-26-000013EDGAR107K words
2025-02-272024-12-310001792044-25-000008EDGAR—
2024-02-282023-12-310001792044-24-000008EDGAR—
2023-02-272022-12-310001792044-23-000008EDGAR—
2022-02-282021-12-310001792044-22-000010EDGAR—
2021-03-012020-12-310001792044-21-000009EDGAR—
2020-05-072019-12-310001193125-20-136001EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001792044-25-000046EDGAR45K words
2025-08-072025-06-300001792044-25-000033EDGAR—
2025-05-082025-03-310001792044-25-000018EDGAR—
2024-11-072024-09-300001792044-24-000033EDGAR—
2024-08-082024-06-300001792044-24-000025EDGAR—
2024-05-092024-03-310001792044-24-000017EDGAR—
2023-11-082023-09-300001792044-23-000033EDGAR—
2023-08-072023-06-300001792044-23-000024EDGAR—
2023-05-082023-03-310001792044-23-000017EDGAR—
2022-11-072022-09-300001792044-22-000036EDGAR—
2022-08-082022-06-300001792044-22-000028EDGAR—
2022-05-092022-03-310001792044-22-000017EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001792044-26-000010EDGAR13K words
2026-02-030001140361-26-003477EDGAR—
2025-12-080001140361-25-044706EDGAR—
2025-12-050001140361-25-044544EDGAR—
2025-11-060001792044-25-000042EDGAR—
2025-10-240001140361-25-039269EDGAR—
2025-08-070001792044-25-000031EDGAR—
2025-08-050001140361-25-028739EDGAR—
2025-05-080001792044-25-000016EDGAR—
2025-05-050001140361-25-017356EDGAR—

101 total filings indexed. 72 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001792044
TickerVTRS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f99d5eeacdc0b439d554e5f4bfadb64baa1f26880ab49cf078b9960cbc707891
parent: 1e92ab41312ca51b29ea88295f1a92860bf858b6b7bfd0b09c423e911aef496e
content hash: 302609bb656d39d8038854473a11a48cd4c3a39f001f4074371d4dfaa6aea659
signed: 2026-04-13T04:48:09.552Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf